Gena Wang
Stock Analyst at Barclays
(3.52)
# 2,184
Out of 4,442 analysts
743
Total ratings
43.9%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Gena Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Initiated Coverage: Buy | $8 → $9 | $2.90 | +210.34% | 15 | May 28, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $71 → $87 | $80.01 | +8.74% | 5 | Dec 21, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $81 → $50 | $28.76 | +73.85% | 42 | Nov 24, 2025 | |
| MRNA Moderna | Maintained: Hold | $25 | $61.00 | -59.02% | 31 | Nov 21, 2025 | |
| KOD Kodiak Sciences | Maintained: Hold | $17 | $37.05 | -54.12% | 27 | Nov 17, 2025 | |
| LEGN Legend Biotech | Maintained: Buy | $94 → $90 | $29.30 | +207.17% | 27 | Nov 13, 2025 | |
| EDIT Editas Medicine | Maintained: Hold | $3 | $2.76 | +8.70% | 31 | Nov 11, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintained: Hold | $56 | $53.99 | +3.72% | 27 | Nov 11, 2025 | |
| VIR Vir Biotechnology | Maintained: Buy | $31 | $10.16 | +205.12% | 24 | Nov 11, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintained: Hold | $414 | $468.42 | -11.62% | 36 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $33 | $11.60 | +184.48% | 12 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1 | $0.074 | +1,251.35% | 27 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 | $8.04 | -75.12% | 22 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $9.95 | +271.86% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $385 | $276.13 | +39.43% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $14 | $15.25 | -8.20% | 33 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $20 | $17.26 | +15.87% | 64 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $68 | $82.13 | -17.20% | 51 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $33.20 | -36.75% | 22 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $9 | $9.31 | -3.33% | 26 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $8.79 | +2.39% | 19 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $460 → $527 | $288.18 | +82.87% | 55 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $95 | $75.99 | +25.02% | 30 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $80 | $56.50 | +41.59% | 35 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 → $62 | $12.81 | +384.00% | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4 → $48 | $30.60 | n/a | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $23.88 | n/a | 13 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $16 → $25 | $7.08 | n/a | 12 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $18 | $11.81 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $6 | $6.98 | n/a | 3 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $21 | $55.95 | n/a | 3 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $21 | $69.62 | n/a | 7 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $30 | $11.16 | n/a | 5 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $5.72 | n/a | 1 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $618.03 | n/a | 1 | Aug 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $24.72 | n/a | 1 | Jul 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $49.04 | n/a | 1 | Jul 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $56 | $1.26 | n/a | 2 | Mar 17, 2015 |
Cellectis
May 28, 2026
Initiated Coverage: Buy
Price Target: $8 → $9
Current: $2.90
Upside: +210.34%
Cytokinetics
Dec 21, 2025
Maintained: Buy
Price Target: $71 → $87
Current: $80.01
Upside: +8.74%
Ultragenyx Pharmaceutical
Nov 24, 2025
Maintained: Buy
Price Target: $81 → $50
Current: $28.76
Upside: +73.85%
Moderna
Nov 21, 2025
Maintained: Hold
Price Target: $25
Current: $61.00
Upside: -59.02%
Kodiak Sciences
Nov 17, 2025
Maintained: Hold
Price Target: $17
Current: $37.05
Upside: -54.12%
Legend Biotech
Nov 13, 2025
Maintained: Buy
Price Target: $94 → $90
Current: $29.30
Upside: +207.17%
Editas Medicine
Nov 11, 2025
Maintained: Hold
Price Target: $3
Current: $2.76
Upside: +8.70%
CRISPR Therapeutics AG
Nov 11, 2025
Maintained: Hold
Price Target: $56
Current: $53.99
Upside: +3.72%
Vir Biotechnology
Nov 11, 2025
Maintained: Buy
Price Target: $31
Current: $10.16
Upside: +205.12%
Vertex Pharmaceuticals
Nov 10, 2025
Maintained: Hold
Price Target: $414
Current: $468.42
Upside: -11.62%
Nov 10, 2025
Maintained: Buy
Price Target: $38 → $33
Current: $11.60
Upside: +184.48%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $1
Current: $0.074
Upside: +1,251.35%
Nov 7, 2025
Maintained: Sell
Price Target: $2
Current: $8.04
Upside: -75.12%
Nov 7, 2025
Maintained: Buy
Price Target: $37
Current: $9.95
Upside: +271.86%
Nov 7, 2025
Maintained: Buy
Price Target: $385
Current: $276.13
Upside: +39.43%
Nov 7, 2025
Maintained: Buy
Price Target: $24 → $14
Current: $15.25
Upside: -8.20%
Nov 5, 2025
Maintained: Hold
Price Target: $22 → $20
Current: $17.26
Upside: +15.87%
Nov 5, 2025
Maintained: Hold
Price Target: $46 → $68
Current: $82.13
Upside: -17.20%
Nov 5, 2025
Maintained: Hold
Price Target: $21
Current: $33.20
Upside: -36.75%
Nov 3, 2025
Maintained: Hold
Price Target: $11 → $9
Current: $9.31
Upside: -3.33%
Nov 3, 2025
Maintained: Buy
Price Target: $10 → $9
Current: $8.79
Upside: +2.39%
Oct 31, 2025
Maintained: Buy
Price Target: $460 → $527
Current: $288.18
Upside: +82.87%
Oct 30, 2025
Maintained: Buy
Price Target: $80 → $95
Current: $75.99
Upside: +25.02%
Oct 28, 2025
Maintained: Buy
Price Target: $86 → $80
Current: $56.50
Upside: +41.59%
Aug 7, 2025
Maintained: Buy
Price Target: $59 → $62
Current: $12.81
Upside: +384.00%
Aug 10, 2023
Rated: Buy
Price Target: $4 → $48
Current: $30.60
Upside: n/a
Dec 22, 2022
Maintained: Hold
Price Target: $7 → $9
Current: $23.88
Upside: n/a
Nov 2, 2022
Upgraded: Hold
Price Target: $16 → $25
Current: $7.08
Upside: n/a
May 13, 2022
Maintained: Buy
Price Target: $32 → $18
Current: $11.81
Upside: n/a
Mar 15, 2022
Maintained: Buy
Price Target: $18 → $6
Current: $6.98
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $19 → $21
Current: $55.95
Upside: n/a
May 12, 2020
Maintained: Hold
Price Target: $20 → $21
Current: $69.62
Upside: n/a
Jun 22, 2017
Initiated Coverage: Buy
Price Target: $23 → $30
Current: $11.16
Upside: n/a
Jan 20, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $5.72
Upside: n/a
Aug 17, 2016
Reiterated: Hold
Price Target: n/a
Current: $618.03
Upside: n/a
Jul 22, 2016
Rated: Buy
Price Target: n/a
Current: $24.72
Upside: n/a
Jul 22, 2016
Rated: Buy
Price Target: n/a
Current: $49.04
Upside: n/a
Mar 17, 2015
Reiterated: Buy
Price Target: $23 → $56
Current: $1.26
Upside: n/a